|
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes |
42.6 |
|
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches |
36.12 |
|
Crizotinib v. DMSO in SW480 cells |
34.35 |
|
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 |
33.77 |
|
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 |
26.31 |
|
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] |
26.31 |
|
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq |
25.89 |
|
Functional role of CPPED1 in trophoblasts. |
25.85 |
|
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] |
23.28 |
|
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] |
21.99 |
|
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function |
21.99 |
|
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors |
21.9 |
|
mRNA-Seq profiling of human developing kidney |
21.89 |
|
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells |
21.64 |
|
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription |
21.21 |
|
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors |
21.05 |
|
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA |
21.04 |
|
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] |
20.78 |
|
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation |
20.78 |
|
Genome wide expression change by RNF168 knocking down in MCF-7 cells |
20.28 |
|
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy |
19.85 |
|
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer |
19.3 |
|
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 |
18.77 |
|
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons |
18.68 |
|
MYCi975 regulates MYC target genes |
18.64 |
|
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells |
18.63 |
|
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division |
18.47 |
|
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors |
18.1 |
|
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome |
17.43 |
|
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq |
17.05 |
|
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts |
17.05 |
|
Inhibition of TNBC metastasis by Gpx1 |
16.88 |
|
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap |
16.27 |
|
Ebola virus (EBOV) infection of ARPE-19 cells |
15.95 |
|
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures |
15.58 |
|
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function |
15.57 |
|
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death |
15.44 |
|
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms |
15.1 |
|
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression |
15.09 |
|
Nucleoporin-mediated regulation of cell identity genes |
15.03 |
|
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT |
15.0 |
|
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex |
14.94 |
|
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes |
14.76 |
|
TFAP2C signalling in human fibroblasts |
14.68 |
|
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] |
14.12 |
|
Ribosomal footprinting of CN34-Parental and CN34-LM1a |
14.09 |
|
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines |
13.81 |
|
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter |
13.29 |
|
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] |
12.9 |
|
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer |
12.9 |
|
Ribosomal footprinting of MDA-Parental and MDA-LM2 |
12.82 |
|
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] |
12.78 |
|
Lineage specific differentiation is influenced by state of human pluripotency |
12.78 |
|
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells |
12.5 |
|
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells |
12.4 |
|
Transcriptome-wide response to synthetic chromatin protein PcTF |
12.2 |
|
Genome wide expression change by RNF168 knocking down in NEC cells |
12.16 |
|
RNA-seq of cells with TET1 knockout |
12.11 |
|
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy |
11.95 |
|
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 |
11.61 |
|
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload |
11.54 |
|
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown |
11.54 |
|
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues |
11.54 |
|
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) |
11.54 |
|
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas |
11.11 |
|
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs |
11.06 |
|
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing |
11.05 |
|
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition |
10.77 |
|
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] |
10.77 |
|
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 |
10.74 |
|
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells |
10.58 |
|
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] |
10.57 |
|
Transcriptome-wide identification of splicing defects upon XAB2 knockdown |
10.57 |
|
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer |
10.52 |
|
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion |
10.45 |
|
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] |
10.44 |
|
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF |
10.44 |
|
Expression level comparison under dividing and quiescent states in human primary fibroblasts |
10.3 |
|
RNA-seq analysis of the human fetal kidney. |
10.27 |
|
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells |
10.27 |
|
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression |
10.17 |
|
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells |
10.15 |
|
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. |
10.14 |
|
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. |
10.08 |
|
RNA-seq analyses of human prostate cancer cells |
10.04 |
|
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance |
9.99 |
|
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing |
9.97 |
|
Selective expression of long non-coding RNAs in a breast cancer cell progression model |
9.93 |
|
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection |
9.84 |
|
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection |
9.84 |
|
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference |
9.67 |
|
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] |
9.67 |
|
Genetic disruption of COX-1 inhibits multiple oncogenic pathways |
9.53 |
|
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] |
9.46 |
|
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine |
9.42 |
|
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium |
9.4 |
|
hTERT promotes cell adhesion and migration independent of telomerase activity |
9.37 |
|
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] |
9.29 |
|
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells |
9.24 |
|
Genes significantly down or Up-regulated upon RNF219 knockdown |
9.23 |
|
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis |
9.12 |
|
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states |
9.09 |
|
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines |
9.05 |
|
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells |
9.02 |
|
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway |
9.01 |
|
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples |
8.94 |
|
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation |
8.86 |
|
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization |
8.85 |
|
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells |
8.85 |
|
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation |
8.83 |
|
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes |
8.79 |
|
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic |
8.74 |
|
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq |
8.73 |
|
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 |
8.69 |
|
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies |
8.65 |
|
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway |
8.64 |
|
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant |
8.63 |
|
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant |
8.63 |
|
Effect of PBK knockdown on C4-2 cell transcriptome |
8.58 |
|
Disruption of the exocyst induces podocyte loss and dysfunction |
8.48 |
|
Noncoding regions are the main source of targetable tumor-specific antigens |
8.44 |
|
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II |
8.43 |
|
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib |
8.42 |
|
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] |
8.35 |
|
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) |
8.34 |
|
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer |
8.34 |
|
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes |
8.32 |
|
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s |
8.3 |
|
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy |
8.29 |
|
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown |
8.27 |
|
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy |
8.27 |
|
RNA-seq of young and quiescent MRC-5 human fibroblasts |
8.27 |
|
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth |
8.22 |
|
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] |
8.22 |
|
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] |
8.22 |
|
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 |
8.14 |
|
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 |
8.11 |
|
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells |
8.05 |
|
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription |
8.04 |
|
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes |
8.02 |
|
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells |
7.96 |
|
Active translatome profiling with RiboLace in MCF7 cells |
7.94 |
|
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection |
7.93 |
|
Global Mapping of Human RNA-RNA Interactions |
7.91 |
|
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes |
7.88 |
|
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown |
7.81 |
|
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders |
7.78 |
|
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells |
7.77 |
|
Dtx3L and Androgen Signaling in Prostate Cancer |
7.77 |
|
Effect of mitochondria deficiency on senescence-associated gene expression |
7.75 |
|
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA |
7.7 |
|
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer |
7.6 |
|
Human cell line and subcutaneous tumor |
7.57 |
|
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor |
7.55 |
|
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 |
7.51 |
|
SLIGRL-induced gene expression changes in NHEK cells |
7.48 |
|
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology |
7.47 |
|
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs |
7.43 |
|
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation |
7.41 |
|
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors |
7.3 |
|
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] |
7.24 |
|
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons |
7.2 |
|
EWS-Fli and LNC regulated genes in comparison to GFP samples |
7.11 |
|
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions |
7.09 |
|
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] |
7.05 |
|
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells |
7.04 |
|
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells |
6.94 |
|
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] |
6.93 |
|
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells |
6.93 |
|
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. |
6.93 |
|
Transcriptome profiling of 5 human adenocarcinoma cell lines |
6.92 |
|
The role of FAM46C in myeloma cells |
6.92 |
|
The role of FAM46C in myeloma cells [sequencing] |
6.92 |
|
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma |
6.89 |
|
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor |
6.86 |
|
RNAseq Analysis in glioblastoma cells treated with Mepazine |
6.85 |
|
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] |
6.84 |
|
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing |
6.83 |
|
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] |
6.81 |
|
HNF1 regulates critical functions of the human epididymis epithelium. |
6.81 |
|
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq |
6.81 |
|
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines |
6.77 |
|
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq |
6.72 |
|
Conservative alteration of chromosomal expression pattern across human solid tumor types |
6.72 |
|
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients |
6.7 |
|
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) |
6.65 |
|
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin |
6.65 |
|
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. |
6.61 |
|
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA |
6.61 |
|
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] |
6.6 |
|
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors |
6.59 |
|
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 |
6.57 |
|
BAF controls genome accessibility |
6.57 |
|
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma |
6.56 |
|
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance |
6.56 |
|
Transcriptomic analysis of LSD1 |
6.52 |
|
Transcriptome of human keratinocytes with or without HPV16 oncogene expression |
6.5 |
|
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis |
6.48 |
|
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids |
6.48 |
|
CDK12 mediated transcriptional regulation in U2OS cells |
6.44 |
|
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS |
6.41 |
|
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis |
6.4 |
|
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] |
6.37 |
|
The transcriptome effect of overexpressing EZH2 in MCF7 |
6.36 |
|
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) |
6.35 |
|
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming |
6.35 |
|
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration |
6.32 |
|
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. |
6.28 |
|
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. |
6.28 |
|
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively |
6.26 |
|
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L |
6.24 |
|
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen |
6.23 |
|
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II |
6.22 |
|
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes |
6.22 |
|
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] |
6.22 |
|
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 |
6.21 |
|
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis |
6.2 |
|
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer |
6.17 |
|
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness |
6.16 |
|
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro |
6.16 |
|
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) |
6.14 |
|
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell |
6.13 |
|
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells |
6.11 |
|
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes |
6.1 |
|
Androgen Receptor-regulated genes in prostate cancer cells |
6.06 |
|
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells |
6.06 |
|
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer |
6.05 |
|
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer |
6.02 |
|
Identification of Sin3B regulated genes during quiescence |
5.98 |
|
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions |
5.98 |
|
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma |
5.96 |
|
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) |
5.96 |
|
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells |
5.94 |
|
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. |
5.93 |
|
RNA-seq analysis upon ARID1B overexpression |
5.89 |
|
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells |
5.88 |
|
EGR1-controlled transcriptome of T HESCs |
5.87 |
|
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA |
5.81 |
|
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma |
5.8 |
|
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown |
5.77 |
|
Gene Expression Profiling of SPOP Knocked Down Cell |
5.74 |
|
Cystathionine-β-Synthase Promotes Colon Carcinogenesis |
5.73 |
|
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line |
5.71 |
|
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression |
5.69 |
|
RNA-seq of RKO cells with cTAZ KO or putback |
5.64 |
|
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype |
5.63 |
|
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo |
5.63 |
|
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions |
5.63 |
|
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 |
5.59 |
|
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells |
5.55 |
|
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide |
5.52 |
|
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. |
5.42 |
|
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration |
5.39 |
|
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA |
5.39 |
|
Transcriptomic analyssis following EHMT1/2 inhibition |
5.32 |
|
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation |
5.31 |
|
Aneuploidy triggers an immune response |
5.31 |
|
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells |
5.29 |
|
Gene expression profile in breast cancer cells |
5.29 |
|
Analysis of transcriptional regulation by Myt1 and Myt1l |
5.24 |
|
EWSR1 influences alternative splicing through direct and indirect mechanisms |
5.22 |
|
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest |
5.19 |
|
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells |
5.17 |
|
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) |
5.17 |
|
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates |
5.17 |
|
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] |
5.16 |
|
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer |
5.16 |
|
IL-33 activates tumor stroma to promote intestinal polyposis |
5.14 |
|
RNA-Seq with and without RNase treatment in PCa cell lines |
5.12 |
|
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis |
5.11 |
|
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] |
5.11 |
|
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development |
5.11 |
|
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] |
5.11 |
|
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer |
5.11 |
|
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] |
5.08 |
|
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk |
5.08 |
|
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines |
5.05 |
|
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] |
5.05 |
|
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes |
5.04 |
|
Convergent roles of ATF3 and CSL in chromatin control of CAF activation |
5.01 |
|
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] |
5.01 |
|
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors |
4.97 |
|
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU |
4.97 |
|
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU |
4.97 |
|
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays |
4.94 |
|
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines |
4.94 |
|
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] |
4.94 |
|
Differetially expressed genes after hTR overexpression in U2OS cells |
4.94 |
|
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization |
4.92 |
|
Illumina Total RNA-seq in HeLa |
4.91 |
|
RNA-seq analysis of control and Myc-induced U2OS cells |
4.84 |
|
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay |
4.83 |
|
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 |
4.8 |
|
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs |
4.74 |
|
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma |
4.74 |
|
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) |
4.74 |
|
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells |
4.72 |
|
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation |
4.71 |
|
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma |
4.7 |
|
Splicing and epigenetic factors jointly regulate epidermal differentiation |
4.7 |
|
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing |
4.68 |
|
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis |
4.68 |
|
RNA-Seq of PRMT1 overexpression ECA109 cells |
4.65 |
|
Next generation sequencing of small RNAs isolated from exosomes in human semen |
4.62 |
|
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] |
4.62 |
|
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF |
4.62 |
|
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells |
4.53 |
|
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering |
4.53 |
|
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis |
4.49 |
|
CD73 knockdown effect in pancreatic cancer cell lines |
4.48 |
|
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy |
4.47 |
|
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family |
4.42 |
|
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) |
4.42 |
|
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes |
4.42 |
|
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] |
4.38 |
|
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice |
4.38 |
|
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. |
4.35 |
|
Activity-dependent transcriptional changes in human neurons |
4.35 |
|
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells |
4.26 |
|
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 |
4.26 |
|
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 |
4.26 |
|
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown |
4.2 |
|
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals |
4.18 |
|
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) |
4.14 |
|
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A |
4.14 |
|
DRB/GRO-Seq -/+ UV |
4.11 |
|
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity |
4.1 |
|
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis |
4.1 |
|
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications |
4.08 |
|
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene |
4.07 |
|
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death |
4.05 |
|
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells |
4.03 |
|
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles |
4.03 |
|
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq |
3.95 |
|
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity |
3.89 |
|
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes |
3.87 |
|
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer |
3.84 |
|
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] |
3.79 |
|
Gene expression analysis upon mtDNA depletion [RNA-seq] |
3.78 |
|
Gene expression analysis upon mtDNA depletion |
3.78 |
|
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq |
3.77 |
|
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models |
3.73 |
|
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] |
3.73 |
|
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA |
3.71 |
|
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation |
3.7 |
|
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response |
3.7 |
|
Genome-wide analysis of Dengue virus 2 infected cells |
3.66 |
|
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) |
3.63 |
|
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy |
3.62 |
|
RNA sequencing analysis of selumetinib-resistant CRC cells lines |
3.6 |
|
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes |
3.57 |
|
Gene expression profile of human placenta from T. Cruzi infected mothers |
3.55 |
|
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles |
3.54 |
|
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] |
3.43 |
|
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence |
3.43 |
|
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells |
3.41 |
|
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] |
3.4 |
|
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells |
3.39 |
|
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells |
3.34 |
|
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks |
3.33 |
|
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis |
3.29 |
|
Common inflammatory pathways between NEC and Crohn's disease |
3.26 |
|
Differential effects of estrogen receptor beta isoforms on glioblastoma progression |
3.26 |
|
MRTF activates TEAD-YAP target gene expression |
3.23 |
|
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist |
3.21 |
|
BBBomics - Human Blood Brain Barrier Transcriptomics Hub |
3.16 |
|
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] |
3.16 |
|
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] |
3.14 |
|
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. |
3.14 |
|
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression |
3.13 |
|
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells |
3.12 |
|
Single-cell analysis of human kidney organoids |
3.1 |
|
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs |
3.07 |
|
Ribosome profiling upon inhibition of eIF4A |
3.06 |
|
Genome-wide discovery of human splicing branchpoints [RNAse] |
3.04 |
|
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin |
3.03 |
|
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC |
3.02 |
|
Effect of PRDM11 depletion in U2932 cells |
3.01 |
|
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction |
2.99 |
|
Toxoplasma gondii infection of human retinal pigment epithelial cells |
2.97 |
|
Identification of differentially expressed genes between senescence and senescence bypass cells |
2.95 |
|
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine |
2.95 |
|
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] |
2.89 |
|
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer |
2.89 |
|
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns |
2.87 |
|
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation |
2.87 |
|
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia |
2.82 |
|
Epigenetic reprogramming of melanoma cells by vitamin C treatment |
2.81 |
|
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') |
2.8 |
|
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure |
2.79 |
|
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown |
2.79 |
|
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK |
2.72 |
|
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes |
2.62 |
|
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling |
2.62 |
|
hnRNP L protects mRNAs from nonsense-mediated mRNA decay |
2.61 |
|
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles |
2.59 |
|
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) |
2.53 |
|
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 |
2.53 |
|
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection |
2.52 |
|
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells |
2.46 |
|
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) |
2.46 |
|
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes |
2.45 |
|
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. |
2.42 |
|
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells |
2.41 |
|
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression |
2.36 |
|
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) |
2.3 |
|
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain |
2.3 |
|
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes |
2.29 |
|
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process |
2.26 |
|
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) |
2.26 |
|
An siRNA screen identifies CHD4 as a target for epigenetic therapy |
2.22 |
|
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq |
2.21 |
|
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) |
2.2 |
|
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells |
2.2 |
|
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 |
2.2 |
|
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells |
2.18 |
|
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines |
2.12 |
|
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding |
2.09 |
|
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] |
2.05 |
|
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum |
1.99 |
|
The circadian transcriptional landscape in primary human mammary epithelial cells |
1.94 |
|
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes |
1.93 |
|
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] |
1.89 |
|
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. |
1.86 |
|
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT |
1.86 |
|
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer |
1.86 |
|
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks |
1.8 |
|
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation |
1.73 |
|
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 |
1.73 |
|
Effect of nuclear IL-33 on gene expression |
1.6 |
|
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner |
1.55 |
|
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer |
1.54 |
|
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate |
1.53 |
|
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression |
1.51 |
|
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] |
1.48 |
|
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. |
1.48 |
|
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST |
1.35 |
|
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity |
1.3 |
|
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis |
1.27 |
|
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. |
1.19 |
|
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] |
1.19 |
|
Transposon-based construction of strand-specific RNA-seq libraries |
1.1 |
|
hESC neural differentiation |
1.08 |
|
RNA-seq analysis of gene expression patterns during hESC neural differentiation |
1.08 |
|
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling |
1.01 |
|
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation |
1.0 |
|
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] |
0.96 |
|
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. |
0.96 |
|
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers |
0.96 |
|
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] |
0.96 |
|
The contribution of Alu exons to the human proteome |
0.93 |
|
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia |
0.9 |
|
m6A-dependent regulation of messenger RNA stability |
0.88 |
|
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] |
0.86 |
|
WNT signaling memory is required for ACTIVIN to function as a morphogen |
0.85 |
|
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells |
0.82 |
|
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. |
0.81 |
|
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence |
0.81 |
|
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues |
0.8 |
|
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo |
0.76 |
|
single cell RNA-seq from GM12878 (ENCSR673UIY) |
0.76 |
|
Induction of Cardiomyocyte Proliferation [pz-822_human] |
0.75 |
|
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration |
0.75 |
|
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] |
0.71 |
|
eRNA: A graphic user interface-based tool for RNA sequencing data analysis |
0.71 |
|
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients |
0.6 |
|
A code of mono-phosphorylation modulates the function of RB. |
0.58 |
|
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration |
0.57 |
|
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage |
0.57 |
|
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons |
0.48 |
|
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes |
0.46 |
|
ADAR1-editing of cellular and measles virus-derived duplex RNA |
0.46 |
|
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells |
0.45 |
|
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 |
0.42 |
|
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth |
0.41 |
|
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes |
0.39 |
|
Gene expression of collecting duct carcinoma of the kidney |
0.37 |
|
Structure and degradation of circular RNAs regulate PKR activation in innate immunity |
0.36 |
|
HBEC-shp53-PCHD7 |
0.35 |
|
MCF-7 as a model for functional analysis of breast cancer risk variants |
0.33 |
|
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage |
0.3 |
|
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks |
0.27 |
|
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons |
0.27 |
|
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics |
0.26 |
|
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 |
0.24 |
|
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line |
0.24 |
|
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq |
0.23 |
|
Transcriptome-wide modulation of splicing by the exon junction complex |
0.2 |
|
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq |
0.19 |
|
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing |
0.19 |
|
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression |
0.16 |
|
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells |
0.16 |
|
Modulation of nonsense-mediated decay by rapamycin |
0.15 |
|
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells |
0.12 |
|
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer |
0.11 |
|
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) |
0.1 |
|
High-resolution comparative analysis of great ape genomes |
0.08 |
|
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation |
0.05 |
|
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development |
0.05 |
|
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly |
0.02 |